Upcoming event

From October 15 to October 19, Radboud translational medicine will attend the 29th annual congress of the European Association of Nuclear Medicine.
Visit us at booth #59!

Upcoming event

Other news

LinkedIn post ESRR2024

LinkedIn post ESRR2024

šŸ“¢ Important update on EU #GMP Annex 1 at #ESRR2024!  The revised EU GMP Annex 1, effecti...

Read more

ABX has received marketing authorisation for the radiotracer RadeluminĀ® in Germany

ABX has received marketing authorisation for the radiotracer RadeluminĀ® in Germany

ABX has received marketing authorisation for the radiotracer RadeluminĀ® in Germany! This marks the 8...

Read more

GMP-certificate received

GMP-certificate received

Today we received our GMP-certificate!The results of the inspection were excellent and no shortcomin...

Read more

RTM receives marketing authorisation for Fludeoxyglucose (18F)

RTM receives marketing authorisation for Fludeoxyglucose (18F)

We are happy to announce that RTM has received marketing authorization for 18F-FDG of 17 July 2018....

Read more

Interested in a collaboration?

Contact us to discuss the possibilities.